Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma (vol 7, pg 199, 2012)

被引：0
|
作者：
La Madrid, Andres Morales [1 ]
Campbell, Nicholas [2 ]
Smith, Sonali [2 ]
Cohn, Susan L. [1 ]
Salgia, Ravi [2 ]
机构：
[1] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Med, Chicago, IL 60637 USA
来源：
TARGETED ONCOLOGY | 2013年 / 8卷 / 04期
关键词：
D O I：
10.1007/s11523-013-0291-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：301 / 301
页数：1
相关论文
共 50 条
  • [21] Ceritinib for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer
    Landi, Lorenza
    Cappuzzo, Federico
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (02) : 203 - 214
  • [22] Sequencing of ALK Inhibitors in ALK+ Non-Small Cell Lung Cancer
    Shirish M. Gadgeel
    [J]. Current Treatment Options in Oncology, 2017, 18
  • [23] Peripheral T Cell Non-Hodgkin's Lymphoma following Treatment of Hodgkin's Lymphoma
    Chang, Sun Hee
    Lee, Hye Ran
    [J]. CASE REPORTS IN ONCOLOGICAL MEDICINE, 2015, 2015
  • [24] Targeting stemness is an effective strategy to control EML4-ALK+ non-small cell lung cancer cells
    Oh, Se Jin
    Noh, Kyung Hee
    Lee, Young-Ho
    Hong, Soon-Oh
    Song, Kwon-Ho
    Lee, Hyo-Jung
    Kim, Soyeon
    Kim, Tae Min
    Jeon, Ju-Hong
    Seo, Jae Hong
    Kim, Dong-Wan
    Kim, Tae Woo
    [J]. ONCOTARGET, 2015, 6 (37) : 40255 - 40267
  • [25] Sequencing of ALK Inhibitors in ALK plus Non-Small Cell Lung Cancer
    Gadgeel, Shirish M.
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2017, 18 (06)
  • [26] Management of stage IIIA non-small cell lung cancer (vol 94, pg 922, 2012)
    Veeramachaneni, N. K.
    Feins, R. H.
    Stephenson, B. J. K.
    Edwards, L. J.
    Fernandez, F. G.
    [J]. ANNALS OF THORACIC SURGERY, 2013, 96 (04): : 1532 - 1532
  • [27] Treatment of T-cell non-Hodgkin's lymphoma
    Evens A.M.
    Gartenhaus R.B.
    [J]. Current Treatment Options in Oncology, 2004, 5 (4) : 289 - 303
  • [28] The presentation of small-cell lung cancer with metastatic carcinomatous encephalitis in a non-Hodgkin's lymphoma patient
    Tyvaert, L
    Ozsancak, C
    Dubois, F
    Tréhant, G
    Destée, A
    Defebvre, L
    [J]. REVUE NEUROLOGIQUE, 2004, 160 (6-7) : 685 - 695
  • [29] Pharmacodynamic profile of prolonged etoposide administration in patients with small cell lung cancer and non-Hodgkin's lymphoma
    Higa, GM
    Sarkar, MA
    DeVore, RF
    [J]. PHARMACOTHERAPY, 1999, 19 (01): : 101 - 107
  • [30] Therapeutic Strategy for Treatment of Metastatic Non-Small Cell Lung Cancer
    Berhoune, Malik
    Banu, Eugeniu
    Scotte, Florian
    Prognon, Patrice
    Oudard, Stephane
    Bonan, Brigitte
    [J]. ANNALS OF PHARMACOTHERAPY, 2008, 42 (11) : 1640 - 1652
12345